VEVZUO 120 mg/1.7 ml sol inj flac perf 1 pce

7680701420012 CH-70142 M05BX04 07.16.1.

Active substances:

No images available

Details

Product number
7014201
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
denosumabum 120 mg, natrii acetas trihydricus corresp. natrium 0.5 mg, acidum aceticum glaciale, sorbitolum 79.9 mg, polysorbatum 20, natrii hydroxidum aut acidum aceticum ad pH, aqua ad iniectabile ad solutionem pro 1.7 ml.

Articles (1)

Vevzuo 120 mg/1.7 ml (70 mg/ml), Injektionslösung
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
denosumabum
120.0 MG Substance Wirkstoff (Principe actif)
natrii acetas trihydricus
- Substance HNIDK
natrium
0.5 MG Substance HBESI
acidum aceticum glaciale
- Substance HNIDK
sorbitolum
79.9 MG Substance HBESI
polysorbatum 20
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
acidum aceticum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
70142
Drug name
Vevzuo, Injektionslösung
Galenic form
LSINJ
ATC Code
M05BX04
Authorization status
Z
Dispensation category
A
First authorization
18/11/2025
Authorization expiration date
17/11/2030
IT number
07.16.1.
Domain
Human medicine
Field of application
Knochenmetastasen solider Tumoren; Riesenzelltumoren des Knochens

Packaging details

Description (FR)
VEVZUO 120 mg/1.7 ml sol inj flac perf 1 pce
Description (DE)
VEVZUO 120 mg/1.7 ml Inj Lös Durchstf 1 Stk
Market launch
01/10/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data